產品詳情
簡單介紹：
Anti-ELL抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-ELL抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-ELL
Cat. Number:
Anti-ELL抗體KL-8515R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Eukaryotic RNA polymerase II mediates the synthesis of mature and functional messenger RNA. This is a multistep process,Anti-ELL抗體 called the transcription cycle, that includes five stages: preinitiation, promoter, clearance, elongation and termination. Elongation is thought to be a critical stage for the regulation of gene expression. ELL (11-19 lysine-rich leukemia protein), also designated MEN, functions as an RNA polymerase II elongation factor that increases the rate of transcription by suppressing transient pausing by RNA polymerase II. It is also thought to regulate cellular proliferation. ELL is abundantly expressed in peripheral blood leukocytes, skeletal muscle, placenta and testis, with lower expression in spleen, thymus, heart, brain, lung, kidney, liver and ovary. The gene encoding human ELL, which maps to chromosome 19p13.1, is one of several genes that undergo translocation with the MLL gene on chromosome 11q23 in acute myeloid leukemia. MLL (myeloid/lymphoid leukemia, also designated ALL-1 and HRX) regulates embryonal and hematopoietic development.
Also known as:
ELL_HUMAN; Eleven nineteen Anti-ELL抗體lysine rich leukemia gene; Eleven-nineteen lysine-rich leukemia protein; ELL1; elongation factor RNA polymerase II; Men; RNA polymerase II elongation factor; RNA polymerase II elongation factor ELL.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Cow, Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human ELL.
●
Predicted Molecular Weight: 68kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-ELL抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:20-200 IF=1:50-200
Not yet tested in other applications. Anti-ELL抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-ELL抗體
Optimal working dilutions must be determined by the end user.
kl014Bo01 骨成型蛋白4(BMP4)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)
kl014Ca01 骨成型蛋白4(BMP4)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)
kl014Cp01 骨成型蛋白4(BMP4)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)
kl014Ga01 骨成型蛋白4(BMP4)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)
kl014Po01 骨成型蛋白4(BMP4)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)
kl014Rb53 骨成型蛋白4(BMP4)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)
kl015Hu01 骨成型蛋白受體1A(BMPR1A)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein Receptor 1A (BMPR1A)
kl015Mu01 骨成型蛋白受體1A(BMPR1A)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein Receptor 1A (BMPR1A)
kl015Ra01 骨成型蛋白受體1A(BMPR1A)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein Receptor 1A (BMPR1A)
kl017Bo01 上皮性鈣黏附蛋白(CDHE)多克隆抗體 Polyclonal Antibody to Cadherin, Epithelial (CDHE)
kl017Ga01 上皮性鈣黏附蛋白(CDHE)多克隆抗體 Polyclonal Antibody to Cadherin, Epithelial (CDHE)
kl017Hu01 上皮性鈣黏附蛋白(CDHE)多克隆抗體 Polyclonal Antibody to Cadherin, Epithelial (CDHE)
kl017Mu01 上皮性鈣黏附蛋白(CDHE)多克隆抗體 Polyclonal Antibody to Cadherin, Epithelial (CDHE)
kl017Po01 上皮性鈣黏附蛋白(CDHE)多克隆抗體 Polyclonal Antibody to Cadherin, Epithelial (CDHE)
kl017Ra01 上皮性鈣黏附蛋白(CDHE)多克隆抗體 Polyclonal Antibody to Cadherin, Epithelial (CDHE)
kl019Hu01 白介素8受體α(IL8Rα)多克隆抗體 Polyclonal Antibody to Interleukin 8 Receptor Alpha (IL8Ra)
kl019Mu01 白介素8受體α(IL8Rα)多克隆抗體 Polyclonal Antibody to Interleukin 8 Receptor Alpha (IL8Ra)
